Gene · 7980
Papers2,421
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,421
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An overview of DNA methylation markers for early detection of gastric cancer: current status, challenges, and prospects. | Front Genet | 2023 | 37560387 | PubTator, text mining | PubMed |
| Extracellular Vesicles Derived from Human Umbilical Cord Mesenchymal Stem Cells Promote Trophoblast Cell Proliferation and Migration by Targeting TFPI2 in Preeclampsia. | Stem Cells Int | 2023 | 37559681 | PubTator, text mining | PubMed |
| Editorial: Bioinformatics analysis of omics data for biomarker identification in clinical research, Volume II. | Front Genet | 2023 | 37554403 | PubTator, text mining | PubMed |
| Tissue factor pathway inhibitor 2: Current understanding, challenges, and future perspectives. | J Obstet Gynaecol Res | 2023 | 37549932 | PubTator, text mining | PubMed |
| Parameter based 4D dose calculations for proton therapy. | Phys Imaging Radiat Oncol | 2023 | 37520640 | PubTator, text mining | PubMed |
| DNA Methylation in the Fields of Prenatal Diagnosis and Early Detection of Cancers. | Int J Mol Sci | 2023 | 37511475 | PubTator, text mining | PubMed |
| Liquid biopsies for cancer: From bench to clinic. | MedComm (2020) | 2023 | 37492785 | PubTator, text mining | PubMed |
| Dabie bandavirus infection induces macrophagic pyroptosis and this process is attenuated by platelets. | PLoS Negl Trop Dis | 2023 | 37486928 | PubTator, text mining | PubMed |
| Cutaneous lesions and other non-endocrine manifestations of Multiple Endocrine Neoplasia type 1 syndrome. | Front Endocrinol (Lausanne) | 2023 | 37484956 | PubTator, text mining | PubMed |
| Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancer. | Clin Epigenetics | 2023 | 37481552 | PubTator, text mining | PubMed |
| Elucidating shared biomarkers and pathways in kidney stones and diabetes: insights into novel therapeutic targets and the role of resveratrol. | J Transl Med | 2023 | 37480086 | PubTator, text mining | PubMed |
| Cuproptosis-related lncRNAs predict prognosis and immune response of thyroid carcinoma. | Front Genet | 2023 | 37470034 | PubTator, text mining | PubMed |
| Protein structural insights into a rare PCSK9 gain-of-function variant (R496W) causing familial hypercholesterolemia in a Saudi family: whole exome sequencing and computational analysis. | Front Physiol | 2023 | 37469559 | PubTator, text mining | PubMed |
| Lineage Plasticity in SCLC Generates Non-Neuroendocrine Cells Primed for Vasculogenic Mimicry. | J Thorac Oncol | 2023 | 37455012 | PubTator, text mining | PubMed |
| The circadian rhythm: an influential soundtrack in the diabetes story. | Front Endocrinol (Lausanne) | 2023 | 37441501 | PubTator, text mining | PubMed |
| IGFBP2 secretion by mammary adipocytes limits breast cancer invasion. | Sci Adv | 2023 | 37436978 | PubTator, text mining | PubMed |
| Coagulopathy and thromboembolic events a pathogenic mechanism of COVID-19 associated with mortality: An updated review. | J Clin Lab Anal | 2023 | 37431777 | PubTator, text mining | PubMed |
| Imprinted Genes: Genomic Conservation, Transcriptomic Dynamics and Phenomic Significance in Health and Diseases. | Int J Biol Sci | 2023 | 37416777 | PubTator, text mining | PubMed |
The Comparative Bioavailability of Fluticasone and Azelastine Delivered as a Single Fixed Dose Combination (MP-AzeFlu) in Comparison to Two Different Formulations of Azelastine and Fluticasone Propionate Following Intranasal Administration in Healthy Chinese Volunteers. | J Asthma Allergy | 2023 | 37409000 | PubTator, text mining | PubMed |
| Whole genome and RNA sequencing analyses for 254 Taiwanese hepatocellular carcinomas. | Biomark Res | 2023 | 37403120 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7980/papers?page=10